These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30855749)

  • 1. Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.
    Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Turki H; Hall DB; Shear M; Baum P; Padula SJ; Thoma C
    N Engl J Med; 2019 Mar; 380(10):981-983. PubMed ID: 30855749
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of Spesolimab for Generalized Pustular Psoriasis.
    Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Anadkat MJ; Rajeswari S; Hua H; Vulcu SD; Hall D; Tetzlaff K; Thoma C; Lebwohl MG;
    N Engl J Med; 2021 Dec; 385(26):2431-2440. PubMed ID: 34936739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569.
    Wolf J; Ferris LK
    Expert Opin Ther Pat; 2014 Apr; 24(4):477-9. PubMed ID: 24456078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.
    Wilsmann-Theis D; Schnell LM; Ralser-Isselstein V; Bieber T; Schön MP; Hüffmeier U; Mössner R
    J Dermatol; 2018 Jul; 45(7):850-854. PubMed ID: 29655177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
    Burden AD
    Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spesolimab: A Novel Treatment for Pustular Psoriasis.
    Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).
    Okubo Y; Mabuchi T; Iwatsuki K; Elmaraghy H; Torisu-Itakura H; Morisaki Y; Nakajo K
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):325-332. PubMed ID: 30317671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.
    Plachouri KM; Chourdakis V; Georgiou S
    Drugs Today (Barc); 2019 Sep; 55(9):587-593. PubMed ID: 31584575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
    Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
    Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
    Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
    J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.
    Marrakchi S; Guigue P; Renshaw BR; Puel A; Pei XY; Fraitag S; Zribi J; Bal E; Cluzeau C; Chrabieh M; Towne JE; Douangpanya J; Pons C; Mansour S; Serre V; Makni H; Mahfoudh N; Fakhfakh F; Bodemer C; Feingold J; Hadj-Rabia S; Favre M; Genin E; Sahbatou M; Munnich A; Casanova JL; Sims JE; Turki H; Bachelez H; Smahi A
    N Engl J Med; 2011 Aug; 365(7):620-8. PubMed ID: 21848462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
    Zhu T; Jin H; Shu D; Li F; Wu C
    Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.
    Honma M; Nozaki H; Hayashi K; Iinuma S; Ishida-Yamamoto A
    J Dermatol; 2019 Dec; 46(12):e468-e469. PubMed ID: 31502309
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 16. Recapture Rate of Brodalumab in Patients With a Lapse in Treatment.
    Lebwohl M; Cather J; Armstrong A; Van Voorhees A; Jacobson A
    J Drugs Dermatol; 2020 Apr; 19(4):384-387. PubMed ID: 32272515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
    Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
    J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with anti-interleukin-31 receptor A antibody for atopic dermatitis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28394466
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on generalized pustular psoriasis.
    Gooderham MJ; Van Voorhees AS; Lebwohl MG
    Expert Rev Clin Immunol; 2019 Sep; 15(9):907-919. PubMed ID: 31486687
    [No Abstract]   [Full Text] [Related]  

  • 20. Secukinumab in an HIV-positive patient with psoriasis.
    Di Lernia V; Casanova DM; Garlassi E
    J Dtsch Dermatol Ges; 2019 Jun; 17(6):646-648. PubMed ID: 31099169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.